MidCon Midstream LP, an MLP carved out of SandRidge Energy to own saltwater gathering and disposal assets in the Mid-Continent region, filed on Friday with the SEC to raise up to $100 million in an initial public offering.
The Oklahoma City, OK-based company, which was formed in 2014, plans to list on the NYSE but has not selected a ticker. BofA Merrill Lynch and Barclays are the joint bookrunners on the deal. No pricing terms were disclosed, and no income statement was provided....more
Coherus BioSciences, which is developing a biosimilar version of Amgen's Enbrel treatment for inflammatory diseases, announced terms for its IPO on Friday. The Redwood City, CA-based company plans to raise $85 million by offering 6.3 million shares at a price range of $12 to $15. At the midpoint of the proposed range, it would command a fully diluted market value of $508 million.
Enbrel is a self-injected prescription treatment marketed by Amgen (AMGN) that can be used to treat five inflammatory diseases, including rheumatoid arthritis, plaque psoriasis, psoriatic ...more
Electronic Cigarettes International Group, which markets a portfolio of acquired electronic cigarette brands, postponed its uplisting to the NASDAQ on Friday.
The Nunica, MI-based company planned to raise $150 million by offering 33.3 million shares (15% insider) at a price of $4.50. The company currently trades on the OTC Bulletin Board under the symbol ECIG ($4.27 per share; $350 million market cap).
The company was founded in 2010 and booked $17 million in sales for the 12 months ended June 30, 2014. It had planned to list on the NASDAQ under the symbol [ECIG]. Wells Fargo ...more
CB Pharma Acquisition, a biotech-focused blank check company backed by Coronado Biosciences, announced terms for its IPO on Thursday. The Burlington, MA-based company plans to raise $40 million by offering 4.0 million units for $10 each. At that price, CB Pharma Acquisition would command a market value of about $52 million.
The company is led by Lindsay Rosenwald, the CEO of Coronado Biosciences. Coronado trades on the NASDAQ under the symbol CNDO, and has a market cap of about $81 million.
Formed in 2014, CB Pharma Acquisition plans to list on the NASDAQ under the ...more